Dimensional Fund Advisors LP 13D and 13G filings for Supernus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-31 11:55 am Purchase |
2024-10-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Dimensional Fund Advisors LP | 2,882,505 5.200% |
2,882,505 (New Position) |
Filing |